NSBI, ECBC back Halifax Biomedical
Cape Breton medical device maker Halifax Biomedical Inc. has secured a $3 million equity investment to help finance the roll-out of its high-resolution imaging system that allows surgeons to monitor changes in artificial joint replacements and detect implant failure.
Nova Scotia Business Inc. said Friday its venture capital arm has invested $2 million in the company, and that Enterprise Cape Breton Corporation is investing $1 million.
Mabou-based Halifax Biomedical's main product is the roentgen stereophotogrammetric analysis or RSA, which is an X-ray device that allows two simultaneous